As of 2026-09-17, the Relative Valuation of Novocure Ltd (NVCR) is (33.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.72 USD, the upside of Novocure Ltd based on Relative Valuation is -301.8%.
The range of the Relative Valuation is (32.33) - (49.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.3x - 39.1x | 26.0x |
| Forward P/E multiples | 21.9x - 40.1x | 26.9x |
| Fair Price | (32.33) - (49.88) | (33.74) |
| Upside | -293.4% - -398.3% | -301.8% |
| Date | P/E |
| 2026-09-17 | -13.15 |
| 2026-09-16 | -12.71 |
| 2026-09-15 | -12.66 |
| 2026-09-14 | -12.71 |
| 2026-09-11 | -12.16 |
| 2026-09-10 | -12.03 |
| 2026-09-09 | -12.25 |
| 2026-09-08 | -13.21 |
| 2026-09-04 | -14.06 |
| 2026-09-03 | -13.83 |
| 2026-09-02 | -13.98 |
| 2026-09-01 | -13.62 |
| 2026-08-31 | -13.83 |
| 2026-08-28 | -13.97 |
| 2026-08-27 | -14.10 |
| 2026-08-26 | -14.02 |
| 2026-08-25 | -13.81 |
| 2026-08-24 | -13.14 |
| 2026-08-21 | -13.40 |
| 2026-08-20 | -13.93 |
| 2026-08-19 | -14.27 |
| 2026-08-18 | -13.51 |
| 2026-08-17 | -13.74 |
| 2026-08-14 | -13.29 |
| 2026-08-13 | -13.62 |
| 2026-08-12 | -13.79 |
| 2026-08-11 | -13.84 |
| 2026-08-10 | -13.57 |
| 2026-08-07 | -12.85 |
| 2026-08-06 | -12.30 |
| 2026-08-05 | -12.58 |
| 2026-08-04 | -12.75 |
| 2026-08-03 | -12.01 |
| 2026-07-31 | -11.63 |
| 2026-07-30 | -11.94 |
| 2026-07-29 | -11.91 |
| 2026-07-28 | -12.78 |
| 2026-07-27 | -13.35 |
| 2026-07-24 | -13.83 |
| 2026-07-23 | -15.67 |
| 2026-07-22 | -12.20 |
| 2026-07-21 | -12.54 |
| 2026-07-20 | -12.49 |
| 2026-07-17 | -12.48 |
| 2026-07-16 | -12.87 |
| 2026-07-15 | -12.56 |
| 2026-07-14 | -12.19 |
| 2026-07-13 | -12.61 |
| 2026-07-10 | -12.78 |
| 2026-07-09 | -13.55 |